HS-IT201 Injection in the Treatment of Advanced Solid Tumors

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2028

Conditions

Solid Tumor

Interventions

DRUG

HS-IT201 Injection

Adoptive transfer of 5x10\^9-4x10\^10 autologous TIL to patients i.v. in 30-60 minutes.

All Listed Sponsors

collaborator

The Affiliated Hospital of Qingdao University

OTHER

lead

Qingdao Sino-Cell Biomedicine Co., Ltd.

INDUSTRY

NCT06613152 - HS-IT201 Injection in the Treatment of Advanced Solid Tumors | Biotech Hunter | Biotech Hunter